Ironwood医药启动Apraglutide三期Stars-2试验,六月起招募患者

美股速递
Jul 14

Ironwood医药公司已正式启动其候选药物Apraglutide的三期临床试验,项目代号为Stars-2。该试验计划于六月开始,目前正在积极招募符合条件的患者参与。这项研究标志着Apraglutide在研发进程中的一个重要里程碑。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10